Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute E-Cigarette Aerosol Condensate Exposure Disrupts the Transcriptome and Proteome Profiles of Human Bronchial Epithelial BEAS-2B Cells.

Cells·2026
Same author

Interfacial Molecular Interactions as Determinants of Nanostructural Preservation in Ibuprofen-Loaded Nanoemulsions and Nanoemulsion Gels.

Pharmaceutics·2025
Same author

Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells.

Molecules (Basel, Switzerland)·2025
Same author

Correction: Dubljević et al. Genotype-Based Housing as a Potential Confounder in Studies Using Transgenic Mouse Models-Insight from the A53T Mouse Model of Parkinson's Disease. <i>Biomedicines</i> 2025, <i>13</i>, 1506.

Biomedicines·2025
Same author

Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with <i>P</i>-glycoprotein.

Future medicinal chemistry·2025
Same author

PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.

Frontiers in cell and developmental biology·2025

Related Experiment Video

Updated: Aug 28, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

530

Decreased TSPAN14 Expression Contributes to NSCLC Progression.

Mirna Jovanović1, Tijana Stanković1, Sonja Stojković Burić1

  • 1Department of Neurobiology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Despota Stefana 142, 11060 Belgrade, Serbia.

Life (Basel, Switzerland)
|September 23, 2022
PubMed
Summary

Tetraspanin 14 (Tspan14) deficiency correlates with poor survival and increased metastasis in non-small cell lung cancer (NSCLC). Lower Tspan14 expression indicates higher tumor invasiveness and metastatic potential in NSCLC patients.

Keywords:
NSCLCTspan14lung cancermetastasis

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

522
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K

Related Experiment Videos

Last Updated: Aug 28, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

530
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

522
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tetraspanin (Tspan) proteins influence tumor progression, but Tspan14's role in cancer remains unclear.
  • Previous findings suggest TSPAN14 gene inactivation correlates with reduced survival rates in non-small cell lung cancer (NSCLC) patients.

Purpose of the Study:

  • To investigate the association between Tspan14 dysfunction and NSCLC clinicopathological features.
  • To determine the role of Tspan14 in NSCLC progression and metastasis.

Main Methods:

  • Analysis of TSPAN14 expression in NSCLC patient samples.
  • Correlation of gene expression with patient survival and tumor aggressiveness.
  • In vitro studies using NSCLC cell lines to assess metastatic potential.
  • Gene silencing experiments to evaluate Tspan14's effect on matrix-degrading enzymes.

Main Results:

  • TSPAN14 expression was significantly lower in NSCLC tumor cells compared to non-tumor cells.
  • Decreased TSPAN14 expression correlated with lower patient survival and more aggressive tumor types.
  • Reduced Tspan14 levels were linked to increased cancer cell metastatic potential in vitro.
  • Silencing TSPAN14 upregulated MMP-2 and MMP-9, enhancing cancer cell gelatin degradation.

Conclusions:

  • TSPAN14 expression serves as a potential biomarker for NSCLC metastatic potential and disease progression.
  • Loss of Tspan14 function may drive NSCLC invasiveness through matrix degradation.
  • Further research into Tspan14's regulatory mechanisms in NSCLC is warranted.